Loading market dashboard
Poseida Therapeutics, Inc.
PSTXHealthcareNASDAQUS
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Poseida Therapeutics, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2028 | $379.38M | $379.38M - $379.38M | -$31.88M | $0.23 | 1 |
| Dec 2027 | $76.51M | $76.51M - $76.51M | -$6.43M | -$1.17 | 2 |
| Dec 2026 | $44.00M | $44.00M - $44.00M | -$3.70M | -$1.81 | 2 |
| Dec 2025 | $43.33M | $43.33M - $43.33M | -$3.64M | -$1.817 | 2 |
| Dec 2024 | $147.12M | $139.71M - $154.54M | -$12.36M | -$0.727 | 2 |
| Dec 2023 | $88.46M | $88.46M - $88.46M | -$7.43M | -$1.185 | 1 |
| Dec 2022 | $173.47M | $168.23M - $180.79M | -$14.58M | -$0.467 | 1 |
| Dec 2021 | $27.50M | $21.21M - $33.32M | -$2.41M | -$2.294 | 2 |